Aarti Drugs will grow and the stock is cheap

The Indian pharma sector comprises a diverse set of players. There are somnolent multinationals, dictated by the policies of their remote parents. The larger Indian ones, like Dr Reddy’s and Ranbaxy, have tried to go down the path of patent challenges but got entangled in litigation launched by US pharma companies. Smaller and medium-sized Indian...